Inner Nuclear Layer Thickening Is Inversley Proportional to Retinal Ganglion Cell Loss in Optic Neuritis

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Kaushik, Megha ^a   Wang, Chen Yu ^b   Barnett, Michael H ^b   Garrick, Raymond ^c   Parratt, John ^d   Graham, Stuart L ^e   Sriram, Prema ^a,e   Yiannikas, Con ^f   Klistorner, Alexandr ^a,e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

^e MACQUARIE UNIVERSITY   (Australia)

^f ANZAC Research Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GANGLION CELL AND INNER PLEXIFORM LAYER THICKNESS; GENDER; HUMAN; INNER NUCLEAR LAYER THICKNESS; MALE; MEDICAL HISTORY; MULTIPLE SCLEROSIS; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PARAMACULAR RETINAL NERVE FIBER LAYER THICKNESS; RETINA BIPOLAR GANGLION CELL; RETINA DISEASE; RETINA FOVEA; RETINA GANGLION CELL; RETINAL MICROCYST; RETINAL NERVE FIBER LAYER THICKNESS; VISUAL SYSTEM PARAMETERS;

ADULT; CASE-CONTROL STUDIES; CELL COUNT; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OPTIC NEURITIS; RETINAL GANGLION CELLS; RETINAL NEURONS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84884854116     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078341     Document Type: Article

References (28)

1. Arnold AC, (2005) Evolving management of optic neuritis and multiple sclerosis. Am J Ophthalmol 139: 1101-1108. doi:10.1016/j.ajo.2005.01.031. PubMed: 15953446.
2. Albrecht P, Ringelstein M, Müller AK, Keser N, Dietlein T, et al. (2012) Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography. Mult Scler 18: 1422-1429. doi:10.1177/1352458512439237. PubMed: 22389411.
3. Davies EC, Galetta KM, Sackel DJ, Talman LS, Frohman EM, et al. (2011) Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique. J Neuroophthalmol 31: 260-264. doi:10.1097/WNO.0b013e318221b434. PubMed: 21654523.
4. Saidha S, Syc SB, Durbin MK, Eckstein C, Oakley JD, et al. (2011) Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler 17: 1449-1463. doi:10.1177/1352458511418630. PubMed: 21865411.
5. Walter SD, Ishikawa H, Galetta KM, Sakai RE, Feller DJ, et al. (2012) Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology 119: 1250-1257. doi:10.1016/j.ophtha.2011.11.032. PubMed: 22365058.
6. Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, et al. (2012) Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 135: 521-533. doi:10.1093/brain/awr264. PubMed: 22006982.
7. Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R, (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 133: 1591-1601. doi:10.1093/brain/awq080. PubMed: 20410146.
8. Forooghian F, Sproule M, Westall C, Gordon L, Jirawuthiworavong G, et al. (2006) Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies. Doc Ophthalmol 113: 123-132. doi:10.1007/s10633-006-9022-0. PubMed: 16972082.
9. Gundogan FC, Demirkaya S, Sobaci G, (2007) Is optical coherence tomography really a new biomarker candidate in multiple sclerosis?--A structural and functional evaluation. Invest Ophthalmol Vis Sci 48: 5773-5781. doi:10.1167/iovs.07-0834. PubMed: 18055831.
10. Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, et al. (2011) Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 134: 518-533. doi:10.1093/brain/awq346. PubMed: 21252110.
11. Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, et al. (2012) Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 11: 963-972. doi:10.1016/S1474-4422(12)70213-2. PubMed: 23041237.
12. Sriram P, Graham SL, Wang C, Yiannikas C, Garrick R, et al. (2012) Transsynaptic retinal degeneration in optic neuropathies: optical coherence tomography study. Invest Ophthalmol Vis Sci 53: 1271-1275. doi:10.1167/iovs.11-8732. PubMed: 22222509.
13. Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ, (2012) Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain 135: 1786-1793. doi:10.1093/brain/aws098. PubMed: 22539259.
14. Abegg M, Zinkernagel M, Wolf S, (2012) Microcystic macular degeneration from optic neuropathy. Brain 135: e225. doi:10.1093/brain/aws215. PubMed: 22960546.
15. Balk LJ, Killestein J, Polman CH, Uitdehaag BM, Petzold A, (2012) Microcystic macular oedema confirmed, but not specific for multiple sclerosis. Brain 135: e226; author reply:.
16. Barboni P, Carelli V, Savini G, Carbonelli M, La Morgia C, et al. (2013) Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration. Brain.
17. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127. doi:10.1002/ana.1032. PubMed: 11456302.
18. Garas A, Simó M, Holló G, (2011) Nerve fiber layer and macular thinning measured with different imaging methods during the course of acute optic neuritis. Eur J Ophthalmol 21: 473-483. doi:10.5301/EJO.2010.5844. PubMed: 21038310.
19. Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, et al. (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9: 921-932. doi:10.1016/S1474-4422(10)70168-X. PubMed: 20723847.
20. Seigo MA, Sotirchos ES, Newsome S, Babiarz A, Eckstein C, et al. (2012) In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol 259: 2119-2130. doi:10.1007/s00415-012-6466-x. PubMed: 22418995.
21. Wolff B, Basdekidou C, Vasseur V, Mauget-Faÿsse M, Sahel Ja, et al. (2013) RETINAL INNER NUCLEAR LAYER MICROCYSTIC CHANGES IN OPTIC NERVE ATROPHY: A Novel Spectral-Domain OCT Finding. Retina. PubMed: 23644558.
22. Sotirchos ES, Saidha S, Byraiah G, Mealy MA, Ibrahim MA, et al. (2013) In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology 80: 1406-1414. doi:10.1212/WNL.0b013e31828c2f7a. PubMed: 23516321.
23. Gelfand JM, Cree BA, Nolan R, Arnow S, Green AJ, (2013) Microcystic Inner Nuclear Layer Abnormalities and Neuromyelitis Optica. JAMA Neurol, 70: 1-5. PubMed: 23529376.
24. Sigler EJ, Randolph JC, Charles S, (2013) Delayed onset inner nuclear layer cystic changes following internal limiting membrane removal for epimacular membrane. Graefes Arch Clin Exp Ophthalmol, 251: 1679-85. PubMed: 23306785.
25. Petzold A, (2012) Microcystic macular oedema in MS: T2 lesion or black hole? Lancet Neurol 11: 933-934. doi:10.1016/S1474-4422(12)70231-4. PubMed: 23041238.
26. Gelfand JM, Green AJ, (2013) Reply: Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration. Brain.
27. Chen L, Gordon LK, (2005) Ocular manifestations of multiple sclerosis. Curr Opin Ophthalmol 16: 315-320. doi:10.1097/01.icu.0000179804.49842.e2. PubMed: 16175046.
28. Kerrison JB, Flynn T, Green WR, (1994) Retinal pathologic changes in multiple sclerosis. Retina 14: 445-451. PubMed: 7899721.